Skip to content

comprehensive empowerment program in older patients with diabetes

The effect of comprehensive empowerment program on age-related outcomes in older patients with diabetes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220314054282N1
Enrollment
80
Registered
2022-12-19
Start date
2023-01-21
Completion date
Unknown
Last updated
2023-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Being diagnosed of diabetes type 2 for at least one year. Condition 2: Being 65 years old and more. Condition 3: Mark 5 or more in constipation assessment scale. Diabetes mellitus due to underlying condition Constipation

Interventions

Intervention 1: Intervention group: will comprehensive empowerment program besides routine care. The comprehensive empowerment program will be implemented in the physical aspect (introduction to the d

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Being diagnosed of diabetes for at least one year. Being able to speak Farsi. Being 65 years old and more Mark 5 or more in constipation assessment scale The older adult or his/her key caregiver has access and ability to use electronic devices for connecting to the web, watching video and reading text.

Exclusion criteria

Exclusion criteria: Affliction of covid-19 during the in-person sessions, mental health or cognitive disorders Participation in similar empowerment programs Being in the acute and emergency conditions like keto-acidosis, and life-threatening hyperglycemic attacks Not being able to continue the participation (death, intensive care needs, immigrations) Not participating in all sessions or even alternative/compensatory sessions

Design outcomes

Primary

MeasureTime frame
Glycemic control. Timepoint: At first and then 3 months later. Method of measurement: Will be determined by draining 2-3 cc blood and measuring glycosylated hemoglobin at first and then 3 months later.;Constipation. Timepoint: Measuring at the beginning, one month after starting the study and 3 months after starting the study. Method of measurement: Utilizing constipation assessment scale.;Polypharmacy. Timepoint: Measuring at the beginning, one month after starting the study and 3 months after starting the study. Method of measurement: Utilizing Screening Tool of Older persons' potentially inappropriate prescriptions (STOPP) Version 2.;Active aging. Timepoint: Measuring at the beginning, one month after starting the study and 3 months after starting the study. Method of measurement: Active Aging Measurement Instrument.;Health costs. Timepoint: Measuring at the beginning, one month after starting the study and 3 months after starting the study. Method of measurement: Researcher-made questionnaire.;Blood pressure. Timepoint: Measuring at the beginning, one month after starting the study and 3 months after starting the study. Method of measurement: Using manual blood pressure measurement instrument under TRUE consortium standards.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Pazokian

Shahid Beheshti University of Medical Sciences

Pazokian@sbmu.ac.ir+98 21 8865 5372

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026